This story provided by Ohio Northern University HealthWise Pharmacy.
(RxWiki News) The US Food and Drug Administration (FDA) approved a new test that can detect neutralizing antibodies from a past SARS-CoV-2 infection. It s the first test of its kind.
The FDA has granted more than 50 antibody (serology) tests an emergency use authorization (EUA). This newly approved test, called cPass SARS-CoV-2 Neutralization Antibody Detection Kit, was one of them. But this test is different.
This test can detect neutralizing antibodies, which are antibodies that bind to a certain part of a pathogen that has been shown to lower the SARS-CoV-2 viral infection of cells, according to the FDA.